In the BioHarmony Drug Report Database

"Preview" Icon

Bumetanide

Bumex (bumetanide) is a small molecule pharmaceutical. Bumetanide was first approved as Bumex on 1983-02-28. It is used to treat ascites, chronic kidney failure, edema, heart failure, and hypertension amongst others in the USA. The pharmaceutical is active against solute carrier family 12 member 1. In addition, it is known to target solute carrier family 12 member 2 and G-protein coupled receptor 35.

 

Trade Name

 

Bumex
 

Common Name

 

bumetanide
 

ChEMBL ID

 

CHEMBL1072
 

Indication

 

ascites, chronic kidney failure, edema, heart failure, hypertension, liver cirrhosis, nephrotic syndrome, pulmonary edema
 

Drug Class

 

Diuretics (piretanide type)

Image (chem structure or protein)

Bumetanide structure rendering